On the other hand, an oncolytic adenovirus coding for GMCSF (Ad5/3-D24-GMCSF) was shown to induce anti-tumoral immunity and efficacy in patients with advanced breast tumors, including TNBC100. The gene discussed is CSF2; the disease is breast neoplasm.